Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Operating Expenses (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Operating Expenses for 5 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 53.72% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.7 million through Dec 2025, down 19.61% year-over-year, with the annual reading at $60.7 million for FY2025, 19.61% down from the prior year.
  • Operating Expenses for Q4 2025 was $9.4 million at Werewolf Therapeutics, down from $15.7 million in the prior quarter.
  • The five-year high for Operating Expenses was $20.5 million in Q4 2022, with the low at $7.5 million in Q1 2021.
  • Average Operating Expenses over 5 years is $16.0 million, with a median of $16.9 million recorded in 2023.
  • The sharpest move saw Operating Expenses skyrocketed 106.2% in 2022, then tumbled 53.72% in 2025.
  • Over 5 years, Operating Expenses stood at $17.9 million in 2021, then rose by 14.42% to $20.5 million in 2022, then fell by 29.32% to $14.5 million in 2023, then skyrocketed by 40.69% to $20.3 million in 2024, then crashed by 53.72% to $9.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $9.4 million, $15.7 million, and $17.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.